Literature DB >> 7517363

Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4.

B Sadlack1, R Kühn, H Schorle, K Rajewsky, W Müller, I Horak.   

Abstract

Interleukin (IL)-2 and IL-4 are considered as important regulators of growth and differentiation of lymphocytes. We report that in mice made deficient for both IL-2 and IL-4 by gene targeting all major T cell subsets and B cells were normal, indicating that IL-2 and IL-4 are not essential for development of the immune system. Paradoxically, proliferation of T cells was increased in both IL-2 and IL-4-deficient homozygous mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517363     DOI: 10.1002/eji.1830240144

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  30 in total

1.  Interleukin 7 receptor-deficient mice lack gammadelta T cells.

Authors:  K Maki; S Sunaga; Y Komagata; Y Kodaira; A Mabuchi; H Karasuyama; K Yokomuro; J I Miyazaki; K Ikuta
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 2.  Interleukin-2, Interleukin-7, T cell-mediated autoimmunity, and N-glycosylation.

Authors:  Ani Grigorian; Haik Mkhikian; Michael Demetriou
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

Review 3.  Cytokines in the Treatment of Cancer.

Authors:  Kevin C Conlon; Milos D Miljkovic; Thomas A Waldmann
Journal:  J Interferon Cytokine Res       Date:  2018-06-11       Impact factor: 2.607

4.  Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.

Authors:  I B Autenrieth; N Bucheler; E Bohn; G Heinze; I Horak
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

Review 5.  Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.

Authors:  Thomas A Waldmann
Journal:  J Clin Immunol       Date:  2007-01-11       Impact factor: 8.317

6.  Autocrine expression of interleukin-7 rescues lymphoid expansion in interleukin-7-deficient mice.

Authors:  B E Rich
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

7.  Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

Authors:  Kevin C Conlon; Enrico Lugli; Hugh C Welles; Steven A Rosenberg; Antonio Tito Fojo; John C Morris; Thomas A Fleisher; Sigrid P Dubois; Liyanage P Perera; Donn M Stewart; Carolyn K Goldman; Bonita R Bryant; Jean M Decker; Jing Chen; Tat'Yana A Worthy; William D Figg; Cody J Peer; Michael C Sneller; H Clifford Lane; Jason L Yovandich; Stephen P Creekmore; Mario Roederer; Thomas A Waldmann
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

8.  The role of interleukin-4 in ultraviolet B light-induced immunosuppression.

Authors:  A A el-Ghorr; M Norval
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

9.  Blockade of T- and B-lymphocyte development by antibody to the gamma c subunit of the receptors for interleukins 2, 4, and 7.

Authors:  Y W He; R B Levy; T R Malek
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

Review 10.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.